Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
EJNMMI Physics
|
August 27, 2025
Bridging physics and practice: evaluating sensitivity, septal penetration, and detector dead time in terbium-161 gamma-camera imaging
Frida Westerbergh, Lisa McDougall, Philipp Ritt, et al.
Clinical Nuclear Medicine
|
October 25, 2016
First Experience With SPECT/CT Using a 99mTc-Labeled Inhibitor for Prostate-Specific Membrane Antigen in Patients With Biochemical Recurrence of Prostate Cancer
Julia Reinfelder, Torsten Kuwert, Michael Beck, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 12, 2012
Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT
Marco Wiesmüller, Harald H Quick, Bharath Navalpakkam, et al.
Journal of Clinical Medicine
|
June 13, 2020
DSC Brain Perfusion Using Advanced Deconvolution Models in the Diagnostic Work-up of Dementia and Mild Cognitive Impairment: A Semiquantitative Comparison with HMPAO-SPECT-Brain Perfusion
Manuel A Schmidt, Tobias Engelhorn, Stefan Lang, et al.
Clinical Nuclear Medicine
|
February 6, 2018
SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer
Christian Schmidkonz, Michael Cordes, Michael Beck, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 7, 2025
Safety and efficacy of [<sup>177</sup>Lu]Lu-SibuDAB in patients with progressive metastatic castration-resistant prostate cancer
René Fernández, Cristian Soza-Ried, Vasko Kramer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 2, 2025
Biodistribution and dosimetry of [<sup>177</sup>Lu]Lu-SibuDAB in patients with metastatic castration-resistant prostate cancer
Philipp Ritt, René Fernández, Cristian Soza-Ried, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 5, 2018
<sup>68</sup>Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer
Christian Schmidkonz, Michael Cordes, Daniela Schmidt, et al.
Zeitschrift Fur Medizinische Physik
|
May 11, 2026
Applications of artificial intelligence in nuclear medicine
Lena Kaiser, Thomas Wendler, Deni Hardiansyah, et al.
Clinical Nuclear Medicine
|
June 20, 2018
Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate Cancer
Christian Schmidkonz, Michael Cordes, Michael Beck, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
EJNMMI Physics
|
August 27, 2025
Bridging physics and practice: evaluating sensitivity, septal penetration, and detector dead time in terbium-161 gamma-camera imaging
Frida Westerbergh, Lisa McDougall, Philipp Ritt, et al.
Clinical Nuclear Medicine
|
October 25, 2016
First Experience With SPECT/CT Using a 99mTc-Labeled Inhibitor for Prostate-Specific Membrane Antigen in Patients With Biochemical Recurrence of Prostate Cancer
Julia Reinfelder, Torsten Kuwert, Michael Beck, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 12, 2012
Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT
Marco Wiesmüller, Harald H Quick, Bharath Navalpakkam, et al.
Journal of Clinical Medicine
|
June 13, 2020
DSC Brain Perfusion Using Advanced Deconvolution Models in the Diagnostic Work-up of Dementia and Mild Cognitive Impairment: A Semiquantitative Comparison with HMPAO-SPECT-Brain Perfusion
Manuel A Schmidt, Tobias Engelhorn, Stefan Lang, et al.
Clinical Nuclear Medicine
|
February 6, 2018
SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer
Christian Schmidkonz, Michael Cordes, Michael Beck, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 7, 2025
Safety and efficacy of [<sup>177</sup>Lu]Lu-SibuDAB in patients with progressive metastatic castration-resistant prostate cancer
René Fernández, Cristian Soza-Ried, Vasko Kramer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 2, 2025
Biodistribution and dosimetry of [<sup>177</sup>Lu]Lu-SibuDAB in patients with metastatic castration-resistant prostate cancer
Philipp Ritt, René Fernández, Cristian Soza-Ried, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 5, 2018
<sup>68</sup>Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer
Christian Schmidkonz, Michael Cordes, Daniela Schmidt, et al.
Zeitschrift Fur Medizinische Physik
|
May 11, 2026
Applications of artificial intelligence in nuclear medicine
Lena Kaiser, Thomas Wendler, Deni Hardiansyah, et al.
Clinical Nuclear Medicine
|
June 20, 2018
Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate Cancer
Christian Schmidkonz, Michael Cordes, Michael Beck, et al.
Page
of 5